ES2023533A6 - Procedimiento para la preparacion de un peptido de somatostatina. - Google Patents
Procedimiento para la preparacion de un peptido de somatostatina.Info
- Publication number
- ES2023533A6 ES2023533A6 ES8904151A ES8904151A ES2023533A6 ES 2023533 A6 ES2023533 A6 ES 2023533A6 ES 8904151 A ES8904151 A ES 8904151A ES 8904151 A ES8904151 A ES 8904151A ES 2023533 A6 ES2023533 A6 ES 2023533A6
- Authority
- ES
- Spain
- Prior art keywords
- somatostatin
- peptide derivatives
- detectable element
- amino group
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE UN PEPTIDO DE SOMATOSTATINA, COMPRENDE, ENTRE OTRAS VIAS, REACCIONAR UN PEPTIDO O FRAGMENTO PEPTIDO LIBRE DE GRUPO DE PUENTE O GRUPO SEPARADOR, CON EL CORRESPONDIENTE COMPUESTO QUE PROPORCIONA EL GRUPO DE PUENTE O GRUPO SEPARADOR, Y ENLAZAR ENTRE SI UN AGENTE QUELANTE Y DICHO PEPTIDO O FRAGMENTO PEPTIDO MODIFICADO EN FORMA PROTEGIDA O SIN PROTEGER, DE TAL MANERA QUE EL GRUPO QUELANTE SE FIJE SOBRE EL GRUPO N-AMINO DESEADO Y, SI SE REQUIERE, SE SEPARA AL MENOS UN GRUPO PROTECTOR QUE ESTE PRESENTE EN DICHO PEPTIDO. LOS NUEVOS PEPTIDOS DE SOMATOSTATINA ASI OBTENIDOS SON UTILES EN TERAPEUTICA Y PUEDEN SER MARCADOS PARA APLICACIONES DIAGNOSOTICAS Y TERAPEUTICAS IN VIVO.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888828364A GB8828364D0 (en) | 1988-12-05 | 1988-12-05 | Improvements in/relating to organic compounds |
GB898916115A GB8916115D0 (en) | 1989-07-13 | 1989-07-13 | Improvements in or relating to organic compounds |
GB898916761A GB8916761D0 (en) | 1989-07-21 | 1989-07-21 | Improvements in or relating to organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2023533A6 true ES2023533A6 (es) | 1992-01-16 |
Family
ID=27264222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES8904151A Expired - Lifetime ES2023533A6 (es) | 1988-12-05 | 1989-12-05 | Procedimiento para la preparacion de un peptido de somatostatina. |
Country Status (24)
Country | Link |
---|---|
JP (2) | JP2726320B2 (es) |
KR (1) | KR0156541B1 (es) |
AT (1) | AT403476B (es) |
AU (1) | AU633859B2 (es) |
BE (1) | BE1002296A5 (es) |
CA (1) | CA2004532C (es) |
CH (1) | CH678329A5 (es) |
DE (1) | DE3991505B4 (es) |
DK (1) | DK175338B1 (es) |
ES (1) | ES2023533A6 (es) |
FI (1) | FI102540B (es) |
FR (1) | FR2639947B1 (es) |
GB (1) | GB2225579B (es) |
HK (1) | HK189995A (es) |
HU (2) | HUT53375A (es) |
IE (1) | IE62091B1 (es) |
IL (1) | IL92534A (es) |
LU (1) | LU87633A1 (es) |
MY (1) | MY106120A (es) |
NL (1) | NL194828C (es) |
PT (1) | PT92487B (es) |
SA (1) | SA96160495B1 (es) |
SE (1) | SE508799C2 (es) |
WO (1) | WO1990006949A2 (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU639371B2 (en) * | 1987-07-10 | 1993-07-22 | Novartis Ag | Method of treating breast cancer |
DE3845000C2 (de) * | 1987-07-10 | 1998-11-19 | Novartis Ag | Anwendung von Octreotid zur Behandlung von Brustkrebs |
GB9111199D0 (en) * | 1991-05-23 | 1991-07-17 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5443816A (en) * | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
US5460785A (en) * | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
US5985240A (en) * | 1989-08-09 | 1999-11-16 | Rhomed Incorporated | Peptide radiopharmaceutical applications |
US5700444A (en) * | 1992-02-20 | 1997-12-23 | Rhomed Incorporated | Chemotactic peptide pharmaceutical applications |
GB9004017D0 (en) * | 1990-02-22 | 1990-04-18 | Krenning Eric P | Improvements in or relating to organic compounds |
US5382654A (en) * | 1992-02-05 | 1995-01-17 | Mallinckrodt Medical, Inc. | Radiolabelled peptide compounds |
US5443815A (en) * | 1991-11-27 | 1995-08-22 | Diatech, Inc. | Technetium-99m labeled peptides for imaging |
CA2079896A1 (en) * | 1991-02-08 | 1992-08-09 | Arthur E. Bogden | Method of treating benign and malignant proliferative skin disease |
US7238340B1 (en) | 1991-11-27 | 2007-07-03 | Cis Bio International | Monoamine, diamide, thiol-containing metal chelating agents |
US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
AU657770B2 (en) * | 1991-06-03 | 1995-03-23 | Mallinckrodt Medical, Inc. | Radiolabelled somatostatin derivatives, their preparation and use |
ATE196428T1 (de) * | 1991-08-29 | 2000-10-15 | Mallinckrodt Medical Inc | Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen |
US5225180A (en) * | 1991-09-10 | 1993-07-06 | Diatech, Inc. | Technetium-99m labeled somatostatin-derived peptides for imaging |
US5783170A (en) | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
US5738838A (en) * | 1992-02-20 | 1998-04-14 | Rhomed Incorporated | IKVAV peptide radiopharmaceutical applications |
US5556609A (en) * | 1992-02-20 | 1996-09-17 | Rhomed Incorporated | YIGSR peptide radiopharmaceutical applications |
CA2127284C (en) * | 1992-01-03 | 2002-02-05 | Buck A. Rhodes | Protein- and peptide-metal ion pharmaceutical applications |
EP0642357B1 (en) * | 1992-02-05 | 2001-07-25 | Mallinckrodt Inc. | Radiolabelled somatostatin |
US5371184A (en) * | 1992-02-05 | 1994-12-06 | Mallinckrodt Medical, Inc. | Radiolabelled peptide compounds |
US5643549A (en) * | 1992-02-20 | 1997-07-01 | Rhomed Incorporated | Leukostimulatory agent for in vivo leukocyte tagging |
CA2131315A1 (en) * | 1992-03-25 | 1993-09-30 | Geert J. Ensing | Method of intraoperatively detecting and locating tumoral tissues |
US6017512A (en) * | 1992-06-23 | 2000-01-25 | Diatide, Inc. | Radiolabeled peptides |
US5871711A (en) * | 1992-06-23 | 1999-02-16 | Diatide, Inc. | Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
US5620675A (en) | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
IL108308A0 (en) * | 1993-01-12 | 1994-04-12 | Sandoz Ag | Polypeptides, their production and pharmaceutical compositions containing them |
US5650134A (en) * | 1993-01-12 | 1997-07-22 | Novartis Ag (Formerly Sandoz Ltd.) | Peptides |
CA2154667A1 (en) * | 1993-02-02 | 1994-08-18 | Linda M. Gustavson | Directed biodistribution of small molecules |
US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
ES2158897T3 (es) * | 1993-06-23 | 2001-09-16 | Diatide Inc | Peptidos radiomarcados derivados de somatostatina y utilizados en procedimientos de formacion de imagenes y terapeuticos. |
US5932189A (en) * | 1994-07-29 | 1999-08-03 | Diatech, Inc. | Cyclic peptide somatostatin analogs |
CA2190727C (en) * | 1994-05-19 | 2006-07-18 | Sudhakar Kasina | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
US6051206A (en) * | 1994-06-03 | 2000-04-18 | Diatide, Inc | Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
GB9417873D0 (en) | 1994-09-06 | 1994-10-26 | Sandoz Ltd | Organic compounds |
US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
US5632969A (en) * | 1994-10-13 | 1997-05-27 | Merck & Co., Inc. | N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications |
US5830431A (en) * | 1995-06-07 | 1998-11-03 | Mallinckrodt Medical, Inc. | Radiolabeled peptide compositions for site-specific targeting |
GB9708265D0 (en) * | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
FI965181A (fi) | 1996-12-20 | 1998-06-21 | Map Medical Technologies Oy | Polyalkoholi-peptidijohdannaiset |
DE19917713A1 (de) * | 1999-04-09 | 2000-10-19 | Diagnostikforschung Inst | Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik |
US7175953B2 (en) | 1999-04-09 | 2007-02-13 | Institute Fuer Diagnostik Forschung | Short-warp peptide-dye conjugate as contrast agent for optical diagnostic |
US6630570B1 (en) | 1999-04-09 | 2003-10-07 | Insitut für Diagnostikforschung GmbH | Short-chain peptide-dye conjugates as contrast media for optical diagnosis |
US6685914B1 (en) | 1999-09-13 | 2004-02-03 | Bristol-Myers Squibb Pharma Company | Macrocyclic chelants for metallopharmaceuticals |
AU2002254691B8 (en) | 2001-04-23 | 2008-02-14 | Mallinckrodt Inc. | Tc and Re labeler radioactive glycosylated octreotide derivatives |
US7968080B2 (en) | 2003-08-20 | 2011-06-28 | The Regents Of The University Of California | Somatostatin analogs with inhibitory activity to growth hormone release |
CA2539384C (en) * | 2003-09-17 | 2012-08-28 | Board Of Regents, The University Of Texas System | Mechanism-based targeted pancreatic beta cell imaging and therapy |
EP2067786A1 (en) | 2007-12-07 | 2009-06-10 | ITALFARMACO S.p.A. | Novel non selective analogs of somatostatin |
EP2922578B1 (en) | 2012-11-21 | 2018-12-12 | Serene, Llc | Tin-117m comprising somatostatin receptor binding compounds |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1222691A (en) * | 1981-12-29 | 1987-06-09 | Wilhelmus T. Goedemans | Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments |
US4652519A (en) * | 1983-02-03 | 1987-03-24 | Yeda Research And Development Company Limited | Bifunctional chelating agents and process for their production |
US4707352A (en) * | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group |
HUT42101A (en) * | 1985-01-07 | 1987-06-29 | Sandoz Ag | Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds |
DE3511206A1 (de) * | 1985-03-28 | 1986-10-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue polypeptidderivate, ihre herstellung und pharmazeutische praeparate, welche diese polypeptidderivate enthalten |
DE3522638A1 (de) * | 1985-06-25 | 1987-01-08 | Diamalt Ag | Neue somatostatin-derivate |
US4678667A (en) * | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
CA1266344A (en) * | 1986-02-14 | 1990-02-27 | Miki Kurami | High molecular compounds having amino groups, and their utilization |
US4732974A (en) * | 1986-03-05 | 1988-03-22 | Mallinckrodt, Inc. | Metal ion labeling of carrier molecules |
US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
HU906341D0 (en) * | 1986-10-13 | 1991-04-29 | Sandoz Ag | Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance |
CH679045A5 (es) * | 1987-06-29 | 1991-12-13 | Sandoz Ag | |
US5073541A (en) * | 1987-11-18 | 1991-12-17 | Administrators Of The Tulane Educational Fund | Treatment of small cell lung cancer with somatostatin analogs |
BE1003762A3 (fr) * | 1988-11-11 | 1992-06-09 | Sandoz Sa | Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives. |
-
1989
- 1989-11-29 MY MYPI89001655A patent/MY106120A/en unknown
- 1989-11-30 DE DE3991505A patent/DE3991505B4/de not_active Expired - Lifetime
- 1989-11-30 WO PCT/EP1989/001448 patent/WO1990006949A2/en active Application Filing
- 1989-11-30 CH CH2578/90A patent/CH678329A5/de not_active IP Right Cessation
- 1989-11-30 AT AT0901789A patent/AT403476B/de active
- 1989-12-01 GB GB8927255A patent/GB2225579B/en not_active Expired - Lifetime
- 1989-12-04 NL NL8902981A patent/NL194828C/nl not_active IP Right Cessation
- 1989-12-04 AU AU45871/89A patent/AU633859B2/en not_active Expired
- 1989-12-04 JP JP1315124A patent/JP2726320B2/ja not_active Expired - Lifetime
- 1989-12-04 IL IL9253489A patent/IL92534A/en not_active IP Right Cessation
- 1989-12-04 PT PT92487A patent/PT92487B/pt active IP Right Grant
- 1989-12-04 SE SE8904087A patent/SE508799C2/sv unknown
- 1989-12-04 IE IE386689A patent/IE62091B1/en not_active IP Right Cessation
- 1989-12-04 KR KR1019890018033A patent/KR0156541B1/ko not_active IP Right Cessation
- 1989-12-04 CA CA002004532A patent/CA2004532C/en not_active Expired - Lifetime
- 1989-12-04 FI FI895809A patent/FI102540B/fi active IP Right Grant
- 1989-12-04 FR FR8915993A patent/FR2639947B1/fr not_active Expired - Lifetime
- 1989-12-04 HU HU896359A patent/HUT53375A/hu unknown
- 1989-12-05 LU LU87633A patent/LU87633A1/fr unknown
- 1989-12-05 DK DK198906126A patent/DK175338B1/da not_active IP Right Cessation
- 1989-12-05 BE BE8901294A patent/BE1002296A5/fr not_active IP Right Cessation
- 1989-12-05 ES ES8904151A patent/ES2023533A6/es not_active Expired - Lifetime
-
1995
- 1995-06-15 HU HU95P/P00214P patent/HU211468A9/hu unknown
- 1995-12-21 HK HK189995A patent/HK189995A/xx not_active IP Right Cessation
-
1996
- 1996-01-01 SA SA96160495A patent/SA96160495B1/ar unknown
-
1997
- 1997-08-04 JP JP20891597A patent/JP3686503B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY106120A (en) | Peptide derivatives. | |
IL95118A0 (en) | Polypeptide derivatives,their preparation and pharmaceutical compositions containing them | |
Wilkinson | Troponin C from rabbit slow skeletal and cardiac muscle is the product of a single gene | |
García-Garayoa et al. | In vitro and in vivo evaluation of new radiolabeled neurotensin (8–13) analogues with high affinity for NT1 receptors | |
US5225180A (en) | Technetium-99m labeled somatostatin-derived peptides for imaging | |
Einspahr et al. | Crystal structure studies of calcium complexes and implications for biological systems | |
GR3026658T3 (en) | Hydrazino-type radionuclide chelators having an n 3?s configuration | |
ZA954547B (en) | Technetium-99m labeled peptides for imaging | |
DE69326335T2 (de) | Technetium-99M-markierte peptide zur Bilderzeugung | |
ES8800267A1 (es) | Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor | |
EP0877760A4 (es) | ||
JPH08503924A (ja) | 造影および治療用途の放射性標識ソマトスタチン誘導ペプチド | |
EP0975374A4 (en) | RADIO METAL BINDING PEPTIDE ANALOG | |
GB9108652D0 (en) | Immunoreactive compounds | |
ATE302211T1 (de) | Radiometall-bindende analoge von lhrh | |
EP1270585A4 (en) | PEPTIDE DERIVATIVE | |
SE8804164A (es) | ||
AU7528894A (en) | Hydrazino-type n2s2 chelators | |
DE69434384D1 (de) | Metalkomplexbildner | |
CA2069638A1 (en) | Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands | |
GR1002475B (el) | Μεθοδος παρασκευης πεπτιδικων παραγωγων. | |
EP0264953A3 (en) | Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use | |
AU3602695A (en) | Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications | |
FI943306A (fi) | Menetelmä farmaseuttisesti käytt¦kelpoisen radionuklidin kanssa kompleksoidun ligandin valmistamiseksi | |
WATANABE et al. | Amino-Acid Sequence of LC-1 Light Chain of Squid Mantle Muscle Myosin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1A | Transfer granted | ||
FD1A | Patent lapsed |
Effective date: 20101018 |